CDC’s Worst-Case Coronavirus Model: 214 Million Infected, 1.7 Million Dead (Intelligencer)
A recent CDC projection estimated that the U.S. coronavirus epidemic could infect between 160 million and 214 million people over a period of more...
‘Amazing potential.’ UM doctor to start stem cell trial for coronavirus patients (Miami Herald)
BY BEN CONARCK APRIL 16, 2020
A team of doctors at the University of Miami won emergency federal approval to use stem cell therapy on...
FDA Authorizes Athersys (ATHX) to Initiate a Pivotal Clinical Trial!
FDA Authorizes Athersys to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome.
(Editors note: a...
Exosomes, Extracellular Vesicles, and the CoronaVirus.
Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS.
Article #1: the basics in non-scientific terms from Larry...
Adding Corbis Pharma (CRBP) $5.55 to Watch List.
Running Clinical Trials Full Steam With $46 Million Banked in Late February.
Not thinly, but lightly traded. Ready, locked and loaded.
All of the common...
Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.
A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one of its...
Adding Organicell (BPSR) $0.02 to the Watch List.
Organicell (BBSR). New client, studying now. Thinly, thinly traded and expectedly volatile on an intra-day basis. Like what we’ve read so far about their...
Athersys (ATHX) Overview and Due Diligence links (Reddit)
I've (Dalek on Reddit) compiled a list of links that might be useful if you are disorganized like myself. If you are a newcomer...
Immunomedics (IMMU) up 100% Today or $2 Billion in Value & Stand Down VIII:
Bear Comments from Roubini, Jim Chanos, Jim Rogers and James A. Kostohryz
Don't Be That Guy in Denial!
Just like people who are in denial and don't...
Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
- Novellus's patented mRNA-based cell-reprogramming...
Latest article
$269 Million in Cash. $178 Million Market Cap. What are the Odds? Adding to...
Here's the balance sheet.. Imagine being the CEO?
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but...
Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).
Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data.
The press release link below list nearly all of...
Three Stocks Percolating, Up 106%, Up 169%, and up 483%.
Odyssey Marine (OMEX) gained 169%, on a 259 million share day, from where we added it to 2026 Watch list. Society Pass (SOPA) gained...
